Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer

Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer

PurposeHost immunity influences the impact of cancer therapy but the effect of immune status in radioiodine (RAI)-treated differentiated thyroid cancer (DTC) remains obscure. Here we investigated indoleamine 2,3-dioxygenase (IDO) activity as a biomarker of response to RAI in patients with distant me...

Full description

Bibliographic Details
Main Authors: Liang Shi, Rui Duan, Qiong Jia, Wenyu Wu, Jianming Zhou, Shaohua Li, Hao Zhang, Xue Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
differentiated thyroid cancer
radioiodine
indoleamine 2
3-dioxygenase (IDO)
immune suppression
predictive factors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.871792/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.871792/full

Similar Items